Published: 21 February, 2017 | Volume 1 - Issue 1 | Pages: 001-011
The binding ability of anti-VP2 scFvs to different IBDV strains by Elisa. The plates were coated with 300μg/mL scFvs, followed by incubation with different IBDV strains (include I-65, MB, BJ-836, NF-8, GT, B-87), chicken egg yolk antibody and secondary antibody. control1 (without VP2 or IBDV strains), control2 (without egg yolk antibody), control3 (without VP2 and egg yolk antibody), control4 (with BSA to replace VP2, or with Newcastle disease virus (NDV) to replace IBDV), and PBS was as background. S denotes scFv, N denotes control. NDV denotes IBDV was replaced by NDV.